Ocugen, Inc. (OCGN) stock
OCGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.76−0.02 (-2.11%)
Close on Nov 17, 2026Market cap $256.61MP/E –Yield –
Ocugen price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Ocugen's price to book ratio was 71.7× on Jul 31, 2026, against 7.3× a year earlier. Over the last 5 years it ranged from 1.6× to 156.1×, with a median of 7.3×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jul 31, 2026 | 71.7× | −47.7 |
| 2025 | Dec 31, 2025 | 119.3× | +113.6 |
| 2024 | Dec 31, 2024 | 5.8× | +2.8 |
| 2023 | Dec 29, 2023 | 3.0× | −0.3 |
| 2022 | Dec 30, 2022 | 3.3× | −5.2 |
| 2021 | Dec 31, 2021 | 8.5× | −12.1 |
| 2020 | Dec 31, 2020 | 20.6× | −126.2 |
| 2018 | Apr 30, 2018 | 146.8× | +88.0 |
| 2017 | Jul 31, 2017 | 58.8× | −6.9 |
| 2016 | Dec 30, 2016 | 65.7× | +52.8 |
| 2015 | Dec 31, 2015 | 12.8× | – |
See a number that looks wrong?